Ahn KS, Hahm MS, Park EJ, Lee HK, Kim IH: Corosolic acid isolated from the fruit of Crataegus pinnatifida var. psilosa is a protein kinase C inhibitor as well as a cytotoxic agent. Planta Med 1998 Jun; 64(5): 468-70.

Ahumada C, Saenz T, Garcia D, De La Puerta R, Fernandez A, Martinez E: The effects of a triterpene fraction isolated from Crataegus monogyna Jacq. On different acute inflammation models in rats and mice. Leucocyte migration and phospholipase A2 inhibition.J Pharm Pharmacol 1997; 49(3): 329-3.

Al Makdessi S, Sweidan H, Mullner S, Jacob R: Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langerdorff heart. Arzneimittelforschung 1996; 46: 25-27.

Ammon HP, Handel M: Crataegus, toxicology and pharmacology, Part I: Toxicity. Planta Med 1981;43:105-120, 209-239, 313-322. [Article in German].

Bahorun T, Gressier B,Trotin F, Brunet C, Dine T, Luyckx M, Vasseur J, Cazin JC, Pinkas M: Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung 1996; 46(11): 1086-89.

Santini L., Considerazioni sugli effetti terapeutici dell’Elicriso, Edit. Tipografia Salvietti, Castelnuovo Garfagnana, 1948.

Bettiol F., “Elicriso, un fiore per battere la psoriasi”, Farmacia Naturale, n. 8, 1993.